logo
Lords peers vow to fight law on assisted dying as they warn it may not 'see the light of day' despite narrow backing by MPs

Lords peers vow to fight law on assisted dying as they warn it may not 'see the light of day' despite narrow backing by MPs

Daily Mail​3 hours ago

Campaigners last night vowed to fight the assisted dying Bill in the Lords after MPs moved to legalise it in a historic vote.
In a sign of the concern about the Bill, it passed through the Commons by just 23 votes yesterday – 32 fewer than when MPs backed it in principle in November.
MPs questioned whether there was a clear mandate to introduce one of the most significant social changes in Britain for decades.
And peers vowed there would be an 'attritional' fight when the legislation, decried as a 'bad Bill' after multiple amendments were laid and safeguards stripped out, moves to the House of Lords. One warned that it may not 'see the light of day'.
The Commons voted 314 to 291 in favour of allowing terminally ill people to end their lives with the help of the State, meaning that when abstentions are included, a majority of MPs did not back the Bill.
Sir Keir Starmer and Chancellor Rachel Reeves voted in favour, while opponents included Health Secretary Wes Streeting, Deputy Prime Minister Angela Rayner and Tory leader Kemi Badenoch.
Labour MP Kim Leadbeater's Terminally Ill Adults (End of Life) Bill will undergo further scrutiny in the Lords, but peers said there was 'no constitutional reason' why it could not be amended significantly or even thrown out by the Upper House.
Following an emotional debate in the Commons, Ms Leadbeater described the vote as a 'huge moment in time' and said it would 'correct the profound injustices of the status quo and offer a compassionate and safe choice to terminally ill people'.
TV presenter Dame Esther Rantzen, who has terminal lung cancer and led the campaign for assisted dying, said: 'This will make a huge positive difference, protecting millions of terminally ill patients and their families from the agony and loss of dignity created by a bad death.'
But leading opponent Danny Kruger – whose mother, Dame Prue Leith, was outside Westminster campaigning in favour of the legalisation yesterday – said the vote showed support 'is ebbing away very fast'.
The Tory MP added: 'I'm hopeful now, inspired by that debate and by the falling away of support for the Bill, that the Lords will feel they have a real job to do – to examine closely how the Bill will operate and to introduce their own amendments to make it safer, or to reject the Bill altogether.'
Tory peer and former Cabinet minister Mark Harper said it was possible the Bill may not 'see the light of day'. Lord Harper, who is against assisted dying, told the Mail: 'It's not a government Bill and it wasn't in anybody's manifesto, so there is no constitutional reason why the Lords shouldn't do its job properly and amend the Bill considerably if required.'
Baroness Tanni Grey-Thompson – a leading opponent of assisted dying – said disabled people were 'absolutely terrified' about the Bill as she vowed to add significant safeguards in the Lords.
It is thought it will take four years to implement the Bill should it clear the remaining stages this year and receive royal assent, meaning the first assisted death in Britain would take place by 2029.
This would mark the first time the State sanctioned a death since capital punishment was abolished in 1965, and the Government forecasts that up to 4,500 people could end their lives early each year within a decade.
Under the legislation terminally ill people in England and Wales diagnosed with less than six months to live will be allowed to seek medical help to die
Opening the debate in the Commons, Spen Valley MP Ms Leadbeater said her Bill proposed a 'robust process that goes further than any other piece of legislation in the world'. She added:
'Giving dying people choice about how they die is about compassion, control, dignity and bodily autonomy. Surely we should all have the right to decide what happens to our bodies and decide when enough is enough.'
But after the vote, Tory MP Greg Smith said: 'It is not too late for us to step back from the brink and pull the plug on this Bill, which now lacks majority support in the Commons. I trust the House of Lords to scrutinise the Bill in depth and hope it will never reach royal assent.'
Catherine Robinson, from campaign group Right To Life UK, said: 'The Bill leaves the Commons lacking a majority, with fewer than half of all MPs voting for it at its final stage. We will be fighting this Bill at every stage in the House of Lords, where we are confident it can be overturned given its continued loss of support.'
The assisted dying Bill that returned to the Commons yesterday was significantly changed from the one presented to MPs at the second reading vote in November.
Among radical amendments were the removal of the High Court safeguard – with a senior judge replaced by so-called 'suicide panels' made up of a lawyer, psychiatrist and social worker.
The proposed legislation will allow terminally ill adults in England and Wales with fewer than six months to live to apply for an assisted death. Subject to approval by two doctors and an 'expert panel', the terminally ill person would take an approved substance, provided by a doctor but administered only by the person themselves.
Religious groups expressed horror at the Bill's passing.
Bishop of London the Rt Rev Sarah Mullally, who sits in the House of Lords, said her peers 'must oppose' the Bill due to the 'mounting evidence that it is unworkable and unsafe'.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Reckless cyclists who kill pedestrians could be jailed for life as government set to crackdown on 'nightmare' E-bikes
Reckless cyclists who kill pedestrians could be jailed for life as government set to crackdown on 'nightmare' E-bikes

Daily Mail​

time33 minutes ago

  • Daily Mail​

Reckless cyclists who kill pedestrians could be jailed for life as government set to crackdown on 'nightmare' E-bikes

Reckless cyclists who kill or seriously injure pedestrians will face tougher sentences in line with motoring offences. Under changes to the Crime and Policing Bill, a cyclist who kills someone by riding dangerously could face life in prison. Causing serious injury by dangerous cycling – or causing death by careless or inconsiderate cycling – could be met with five years in prison, a fine or both. A serious injury caused by careless or inconsiderate cycling could result in a two-year prison sentence, a fine or both. The law change, which cleared the Commons this week, includes legal e-bikes as well as pedal cycles, the Government said. The Tories agreed to change the law after campaigning by Conservative grandee Iain Duncan Smith – only for it to fall foul of the early general election last year. Sir Iain has worked with Matthew Briggs, whose wife Kim died from head injuries after a collision with a cyclist in London in 2016. Charlie Alliston, who was riding a fixed-gear bike with no front brake, was found guilty of causing bodily harm by 'wanton or furious driving' – a crime under the 1861 Offences Against the Person Act – but cleared of manslaughter. Sir Iain said the change in the law would mean that for the first time there would be specific punishments for 'reckless, dangerous cycling causing injury or death'. The Bill includes e-bikes, which he said were becoming a 'major nightmare' for police, with crimes being committed using them as well as being ridden dangerously. Sir Iain said he hoped the legislation would make it 'worthwhile' for police to arrest someone for such offences. 'Now you have very specific criminal offences at those who misuse and damage people's lives and kill them,' he told BBC Radio 4's Today programme. 'That will now be a specific crime, and will include e-bikes – riding on pavements, smashing into people, causing problems – that becomes a criminal offence.' The Government said it was changing the law to ensure there is an 'appropriate framework of offences to punish dangerous and careless behaviour that results in serious harm to other road users'. The Ministry of Justice said the new offences 'introduce penalties equivalent to those in place if the same level of harm is caused by drivers of other vehicles'. In 2023, four pedestrians were killed and 185 seriously injured after being hit by a cyclist, according to government figures. On average, three pedestrians have been killed per year by cyclists over the past decade.

Ozempic-maker's new fat-busting drug cuts body weight by a quarter - and it comes as a jab or a PILL
Ozempic-maker's new fat-busting drug cuts body weight by a quarter - and it comes as a jab or a PILL

Daily Mail​

time40 minutes ago

  • Daily Mail​

Ozempic-maker's new fat-busting drug cuts body weight by a quarter - and it comes as a jab or a PILL

A new fat-busting drug that is available as a jab or tablet helps patients lose up to a quarter of their body weight, studies suggest. People who received higher doses of amycretin as a weekly injection lost 24.3 per cent of their body weight after 36 weeks of treatment. And those taking daily tablets lost an average of 13.1 per cent of their body weight after 12 weeks, the early stage trials found. Weight loss jabs have been hailed as transformative by NHS leaders. But tablets could be the next big breakthrough in the nation's fight against obesity as they are likely to appeal to a wider audience who are uncomfortable with injecting themselves. An estimated 1.5million Britons use weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out fat jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body—GLP-1 and the amylin receptor. In comparison to amycretin, trials pivotal to getting semaglutide—the ingredient behind Ozempic—approved, show it helped users shed up to 15 per cent of their body weight over 68 weeks. And studies have found rival jab Mounjaro can help obese people lose up to 22.5 per cent of their body weight in 72 weeks. The new amycretin trial involved 125 adults, who took weekly injections of the drug. Those taking the highest dosage (60mg) lost 24.3 per cent after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment, according to findings published in medical journal The Lancet. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1 per cent of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7 per cent, with a third of participants losing 25 per cent or more of their body weight after 72 weeks. GLP-1 injections suffered global shortages after celebrity users sparked a surge in popularity and the NHS has warned people against buying them from unauthorised sources. Professor Sir Stephen Powis, national medical director at NHS England, last week told the NHS ConfedExpo conference in Manchester that weight loss jabs could be doled out as widely as statins if competition in the market brings their price down The country's top doctor warned obesity costs the NHS £11.4billion every year and described the financial burden as 'unsustainable'. From Monday, GPs will be able to prescribe the fat jab mounjaro - also known as tirzepatide - for the first time, in what he labelled an 'exciting milestone'.

Weight loss pill set to rival injections after promising studies
Weight loss pill set to rival injections after promising studies

The Independent

time43 minutes ago

  • The Independent

Weight loss pill set to rival injections after promising studies

A new daily weight loss pill has shown promising results in initial studies. Researchers say amycretin, which can be offered by injection or tablet, helped patients lose a significant amount of weight in the first trials. Those who received higher doses of amycretin as a weekly jab lost 24.3 per cent of their body weight after 36 weeks of treatment, while patients who took daily tablets lost an average of 13.1 per cent of their body weight after 12 weeks. While weight loss jabs have been hailed as transformative by NHS leaders, injections come with additional work for over-stretched health services, so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3 per cent after 36 weeks of treatment. It also showed signs of improving blood sugar levels. Side effects included nausea and vomiting, and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1 per cent of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association 's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7 per cent, with a third of participants losing 25 per cent or more of their body weight after 72 weeks.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store